Why the study?
Myocardial fibrosis is the most serious complication of viral myocarditis, prompting investigation into the therapeutic benefits and mechanisms of lentivirus-mediated human tissue kallikrein gene transfer.
Does lentivirus-mediated hKLK1 gene transfer alleviate myocardial fibrosis and improve cardiac function in mice with viral myocarditis?
Does lentivirus-mediated hKLK1 gene transfer alleviate myocardial fibrosis and improve cardiac function in mice with viral myocarditis?
Lentivirus-mediated hKLK1 gene transfer alleviates myocardial fibrosis and improves cardiac function in a mouse model of viral myocarditis, potentially by downregulating TGF-β1 expression.
Answers are grounded in this paper and cite their sources.
May support preclinical hKLK1 gene therapy development in viral myocarditis; leaves open human translation.
Myocardial fibrosis is the most serious complication of viral myocarditis (VMC). This study aimed to investigate the therapeutic benefits and underlying mechanisms of lentivirus-mediated human tissue kallikrein gene transfer in myocardial fibrosis in VMC mice. We established VMC mouse model via intraperitoneal injection with Coxsackie B3 virus. The effect was then assessed after treatment with vehicle, the empty lentiviral vectors (EZ.null), and the vectors expressing hKLK1 (EZ.hKLK1) via tail vein injection for 30 days, respectively. The results showed that administering EZ.hKLK1 successfully induced hKLK1 overexpression in mouse heart. Compared with EZ.null treatment, EZ.hKLK1 administration significantly reduced the heart/weight ratio, improved cardiac function, and ameliorated myocardial inflammation in VMC mice, suggesting that hKLK1 overexpression alleviates VMC in mice. EZ.hKLK1 administration also significantly abrogated the increased myocardial collagen content, type I/III collagen ratio, TGF-β1 mRNA and protein expression in VMC mice, suggesting that hKLK1 overexpression reduces collagen accumulation and blunts TGF-β1 signaling in the hearts of VMC mice. In conclusion, our results suggest that hKLK1 alleviates myocardial fibrosis in VMC mice, possibly by downregulating TGF-β1 expression.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: